A patient with disseminated superficial actinic porokeratosis (DSAP) undergoing novel systemic treatment with palifermin (a keratinocyte growth factor) during chemotherapy
Version 2 2024-06-18, 08:33Version 2 2024-06-18, 08:33
Version 1 2021-10-21, 09:40Version 1 2021-10-21, 09:40
conference contribution
posted on 2024-06-18, 08:33authored byM Howard, A Hall
A patient with disseminated superficial actinic porokeratosis (DSAP) undergoing novel systemic treatment with palifermin (a keratinocyte growth factor) during chemotherapy